Taro Pharmaceutical Non-GAAP EPS of $1.09 beats by $0.24, revenue of $156.7M beats by $6.8M (NYSE:TARO)
Taro Pharmaceutical press release (TARO): Q2 Non-GAAP EPS of $1.09 beats by $0.24.Revenue of $156.7M ( 6.5% Y|Y) beats by $6.8M.
Taro Pharmaceutical Non-GAAP EPS of $1.09 beats by $0.24, revenue of $156.7M beats by $6.8M (NYSE:TARO)
Taro Pharmaceutical press release (TARO): Q2 Non-GAAP EPS of $1.09 beats by $0.24.Revenue of $156.7M ( 6.5% Y|Y) beats by $6.8M.